Total synthesis and absolute stereochemistry of integric acid

Journal of Organic Chemistry

Volumn 74, Issue 22, 2009, Pages 8878-8881

  Waalboer, Dennis C J ^a   Van Kalkeren, Henri A ^a   Schaapman, Mark C ^a   Van Delft, Floris L ^a   Rutjes, Floris P J T ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABSOLUTE STEREOCHEMISTRY; CHEMICAL EQUATIONS; DIASTEREOISOMERS; OXIDATIVE CLEAVAGES; TOTAL SYNTHESIS;

CHEMICAL REACTIONS; FLUORINE CONTAINING POLYMERS; KETONES; STEREOCHEMISTRY;

ACIDS;

07H239 A; 2,4 DIMETHYLOCT 2 ENOIC ACID; EREMOXYLARIN A; EREMOXYLARIN B; INTEGRIC ACID; NATURAL PRODUCT; UNCLASSIFIED DRUG; XYLARENAL A; XYLARENAL B;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; DIASTEREOISOMER; ELECTROSPRAY MASS SPECTROMETRY; ENANTIOMER; INFRARED SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

CARBOXYLIC ACIDS; MOLECULAR CONFORMATION; NAPHTHALENES; STEREOISOMERISM;

EID: 70449631382     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo901845r     Document Type: Article

References (20)

1. Singh, S. B.; Zink, D.; Polishook, J.; Valentino, D.; Shafiee, A.; Silverman, K.; Felock, P.; Teran, A.; Vilella, D.; Hazuda, D. J.; Lingham, R. B. Tetrahedron Lett. 1999, 40, 8775-8779.
2. (a) Flexner, C. Nat. Rev. Drug Discovery 2007, 6, 959-966.
3. (b) Craigie, R. J. Biol. Chem. 2001, 276, 23213-23216.
4. Deeks, S. G.; Kar, S.; Gubernick, S. I.; Kirkpatrick, P. Nat. Rev. Drug Discovery 2008, 7, 117-118.
5. Smith, C. J.; Morin, N. R.; Bills, G. F.; Dombrowski, A. W.; Salituro, G. M.; Smith, S. K.; Zhao, A.; MacNeil, D. J. J. Org. Chem. 2002, 67, 5001-5004.
6. McDonald, L. A.; Barbieri, L. R.; Bernan, V. S.; Janso, J.; Lassota, P.; Carter, G. T. J. Nat. Prod. 2004, 67, 1565-1567.
7. Shiono, Y.; Murayama, T. Z. Naturforsch. 2005, 60b, 885-890.
8. Diaz, S.; Gonzalez, A.; Bradshaw, B.; Cuesta, J.; Bonjoch, J. J. Org. Chem. 2005, 70, 3749-3752.
9. 3); see: Alcaraz, L.; Macdonald, G.; Ragot, J.; Lewis, N. J.; Taylor, R. J. K. Tetrahedron 1999, 55, 3707-3716.
10. Singh, S. B.; Felock, P.; Hazuda, D. J. Bioorg. Med. Chem. Lett. 2000, 10, 235-238.
11. For an enantioselective synthesis of 8 with Evans' chiral oxazolidinone methodology, see ref 8.
12. For a review on the RAMP/SAMP methodology, see e.g.: Job, A.; Janeck, C. F.; Bettray, W.; Peters, R.; Enders, D. Tetrahedron 2002, 58, 2253-2329.
13. Paquette, L. A.; Wang, T.-Z.; Philippo, C. M. G.; Wang, S. J. Am. Chem. Soc. 1994, 116, 3367-3374.
14. Chowdhury, P. K.; Sharma, R. P.; Barua, J. N. Tetrahedron Lett. 1983, 24, 3383-3384.
15. This selectivity is in accordance with oxidations of similar dienyl acetates: (a) Suryawanshi, S. N.; Fuchs, P. L. J. Org. Chem. 1986, 51, 902-921.
16. (b) Kirk, D. N.; Wiles, J. M. J. Chem. Soc., Chem. Commun. 1970, 1015-1016.
17. (c) Kirk, D. N.; Wiles, J. M. J. Chem. Soc., Chem. Commun. 1970, 518.
18. Barrett, A. G. M.; Carr, R. A. E.; Attwood, S. V.; Richardson, G.; Walshe, N. D. A. J. Org. Chem. 1986, 51, 4840-4856.
19. D + 38.3 (c 0.63, MeOH) (ref 1).
20. 3) chemical shift for the proton at C1 should read as δ 5.52 instead of the erroneously reported δ 5.25 as determined by comparison with an authentic sample (ref 1)